Find Grants for School Districts

Find out if you qualify for verified grants for School Districts. Discover your eligibility and key funding details for School Districts from major foundations and government agencies.

 

$ 100 Trillion
Total Dollars Available

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Deadline: November 13, 2026


Opportunity Number: PAR-25-270

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 13, 2026

Status: Posted

CFDA Numbers: 93.213

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)

Deadline: November 13, 2026


Opportunity Number: PAR-25-269

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 13, 2026

Status: Posted

CFDA Numbers: 93.213

NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)

Deadline: November 13, 2026


Opportunity Number: PAR-25-271

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: November 13, 2026

Status: Posted

CFDA Numbers: 93.213

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Deadline: January 6, 2028


Opportunity Number: PAR-25-188

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: January 6, 2028

Status: Posted

CFDA Numbers: 93.121

Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-300

Agency: National Institutes of Health

Open Date: December 2, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.855

Alcohol Health Services Research (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PA-25-245

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Alcohol Health Services Research (R34 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-192

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)

Deadline: September 7, 2026


Opportunity Number: PA-25-163

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)

Deadline: September 7, 2026


Opportunity Number: PAR-25-193

Agency: National Institutes of Health

Open Date: November 27, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.273

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-179

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-181

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-182

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-183

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-184

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-285

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-180

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-177

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)

Deadline: October 15, 2027


Opportunity Number: PAR-25-178

Agency: National Institutes of Health

Open Date: November 26, 2024

Close Date: October 15, 2027

Status: Posted

CFDA Numbers: 93.242

HIV Prevention and Alcohol (R01 Clinical Trials Optional)

Deadline: May 7, 2026


Opportunity Number: PAS-25-208

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.273

HIV Prevention and Alcohol (R34 Clinical Trials Optional)

Deadline: May 7, 2026


Opportunity Number: PAS-25-161

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.273

NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)

Deadline: March 5, 2026


Opportunity Number: PAR-25-238

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: March 5, 2026

Status: Posted

CFDA Numbers: 93.879

Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PAR-25-289

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PAR-25-288

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.242

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

Deadline: May 7, 2027


Opportunity Number: PAR-25-279

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.396, 93.866, 93.865, 93.286

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

Deadline: May 7, 2027


Opportunity Number: PAR-25-272

Agency: National Institutes of Health

Open Date: November 25, 2024

Close Date: May 7, 2027

Status: Posted

CFDA Numbers: 93.866, 93.396, 93.865

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.